(Q39149761)

9 September 2017

A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease (English)

1 reference

9 September 2017

0 references

Rajiv Agarwal

1

1 reference

9 September 2017

Kevin L Duffin

2

1 reference

9 September 2017

Dennis A Laska

3

1 reference

9 September 2017

James R Voelker

4

1 reference

9 September 2017

Matthew D Breyer

5

1 reference

9 September 2017

Peter G Mitchell

6

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 August 2014

1 reference

Nephrology Dialysis Transplantation

9 September 2017

1 reference

9 September 2017

29

1 reference

9 September 2017

12

1 reference

9 September 2017

2293-2302

1 reference

Temporal trends in the prevalence of diabetic kidney disease in the United States

9 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Kidney disease and increased mortality risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Chronic kidney disease as a coronary disease equivalent--a comparison with diabetes over a decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

The economic burden of progressive chronic kidney disease among patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

The growing economic burden of diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Biomarkers in chronic kidney disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Longitudinal progression trajectory of GFR among patients with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

FGF-23 and secondary hyperparathyroidism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFU255

21 January 2018

Identifiers

DOI

10.1093/NDT/GFU255

1 reference

9 September 2017

1 reference